Market Value7,928,028,000
Total Holdings139
File Date2021-06-10
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ADPT / Adaptive Biotechnologies Corporation
KRON / Kronos Bio, Inc.
TXMD / TherapeuticsMD, Inc.
SRRA / Sierra Oncology Inc
HCAT / Health Catalyst, Inc.
EXAS / Exact Sciences Corporation
/ Cerevel Therapeutics Holdings, Inc. Warrant
STOK / Stoke Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
TLIS / Talis Biomedical Corporation
CTMX / CytomX Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
PHR / Phreesia, Inc.
PRVB / Provention Bio Inc
FMTX / Forma Therapeutics Holdings Inc
FGEN / FibroGen, Inc. Put
SGTX / Sigilon Therapeutics Inc
MORF / Morphic Holding, Inc.
TCRR / Tcr2 Therapeutics Inc
FREQ / Frequency Therapeutics Inc
AVIR / Atea Pharmaceuticals, Inc.
LABP / Landos Biopharma, Inc.
BLSA / BCLS Acquisition Corp - Class A
VBIV / VBI Vaccines Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
LSAQ / LifeSci Acquisition II Corp
VTRS / Viatris Inc.
PHVS / Pharvaris N.V.
CNCE / Concert Pharmaceuticals Inc
SLDB / Solid Biosciences Inc.
SILK / Silk Road Medical, Inc
HSAQ / Health Sciences Acquisitions Corp 2
PMVP / PMV Pharmaceuticals, Inc.
CHRS / Coherus Oncology, Inc.
ISEE / IVERIC bio Inc
SMFR / Sema4 Holdings Corp - Class A
RACB / Research Alliance Corp II - Class A
/ Therapeutics Acquisition Corp. Class A
LYRA / Lyra Therapeutics, Inc.
/ Fusion Networks Holdings, Inc.
PCVX / Vaxcyte, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ATEC / Alphatec Holdings, Inc.
AMWL / American Well Corporation
EIGR / Eiger BioPharmaceuticals, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
NVRO / Nevro Corp.
TSHA / Taysha Gene Therapies, Inc.
RLAY / Relay Therapeutics, Inc.
US761299AB20 / Retrophin Inc Bond
NVTA / Invitae Corporation
US64157FAC77 / Nevro Corp
/ SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
BFLY.WS / Butterfly Network, Inc. - Equity Warrant
QTNT / Quotient Ltd
NARI / Inari Medical, Inc.
ONEM / 1life Healthcare Inc
AGRX / Agile Therapeutics, Inc.
CVM / CEL-SCI Corporation
/ Common Stock
CCCC / C4 Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
US92731L1145 / Vincerx Pharma, Inc.
ONCR / Oncorus, Inc.
CLOV / Clover Health Investments, Corp.
DRIO / DarioHealth Corp.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
PLXP / PLx Pharma Inc.
VYNE / VYNE Therapeutics Inc.
ACAD / ACADIA Pharmaceuticals Inc.
BIIB / Biogen Inc. Call
CMIIU / CM Life Sciences II Inc - Units (1 Ord Share Class A & 1/5 War)
UTHR / United Therapeutics Corporation
ARWR / Arrowhead Pharmaceuticals, Inc.
RACE / Ferrari N.V.
PSTX / Poseida Therapeutics, Inc.
IMTX / Immatics N.V.
LGV.U / Longview Acquisition Corp. II Units, each consisting of one share of Class A and one-fi
ARNA / Arena Pharmaceuticals Inc
GRTX / Galera Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
NBIX / Neurocrine Biosciences, Inc.
ACRS / Aclaris Therapeutics, Inc.
ALBO / Albireo Pharma Inc
LPTX / Leap Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
BIIB / Biogen Inc. Put
MOTS / Motus GI Holdings, Inc.
VRAY / ViewRay Inc.
ATNX / Athenex Inc
DRNA / Dicerna Pharmaceuticals Inc
RNA / Avidity Biosciences, Inc.
ALDX / Aldeyra Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
HMIN / Homeinns Hotel Group
HZNP / Horizon Therapeutics Plc
TNGX / Tango Therapeutics, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
HCAQ / HealthCor Catalio Acquisition Corp - Class A
US19459JAA25 / COLLEGIUM PHARMACEUTICAL INC CONV 2.625% 02/15/2026
KDMN / Kadmon Holdings Inc
NUVB / Nuvation Bio Inc.
OM / Outset Medical, Inc.
COLL / Collegium Pharmaceutical, Inc.
COGT / Cogent Biosciences, Inc.
SRZN / Surrozen, Inc.
VINC / Vincerx Pharma, Inc.
RXDX / Prometheus Biosciences Inc
CRNX / Crinetics Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
VRCA / Verrica Pharmaceuticals Inc.
RGNX / REGENXBIO Inc.
ADMA / ADMA Biologics, Inc.
GBT / Global Blood Therapeutics Inc.
IOVA / Iovance Biotherapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
NEPT / Neptune Wellness Solutions Inc.
SANA / Sana Biotechnology, Inc.
ATHA / Athira Pharma, Inc.
NBTX / Nanobiotix S.A. - Depositary Receipt (Common Stock)
FBRX / Forte Biosciences, Inc.
VERU / Veru Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
CMAX / CareMax, Inc.
CMAX / CareMax, Inc.
MGTX / MeiraGTx Holdings plc
RAPT / RAPT Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
MRUS / Merus N.V.
ATXS / Astria Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
ALLO / Allogene Therapeutics, Inc.